Showing results (31-40 of 2,659) with videos related to
Sort By:
Pageof 266
Acta Psychiatrica Scandinavica. Supplementum|March 18, 2006
Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disordersL Kopala, G Smith, A Malla, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 30, 1998
Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study GroupG Chouinard, L Kopala, A Labelle, et al.The British Journal of Psychiatry. Supplement|September 26, 2002
Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: an interim analysisK P Good, I Kiss, C Buiteman, et al.Schizophrenia Research|January 1, 1995
Obstetric complications and severity of illness in schizophreniaG N Smith, W G Honer, L Kopala, et al.Clinical Chemistry|June 1, 1978
Comparison of product moment and rank correlation coefficients in the assessment of laboratory method-comparison dataP J Cornbleet, M C SheaExpert Opinion on Pharmacotherapy|October 25, 2006
Palifermin: a keratinocyte growth factor that reduces oral mucositis after stem cell transplant for haematological malignanciesAnne W Beaven, Thomas C SheaInternational Psychogeriatrics|October 24, 1998
Donepezil for treatment of dementia with Lewy bodies: a case series of nine patientsC Shea, C MacKnight, K RockwoodNorth Carolina Medical Journal|October 7, 2024
"Success is dependent on prevention and early detection" - A Conversation with Oncologist and Researcher Dr. Thomas C. SheaPeter J Morris, Thomas C SheaDrugs of Today (Barcelona, Spain : 1998)|August 31, 2007
Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplantAnne W Beaven, Thomas C SheaPsychiatry|November 1, 1988
Contemporary psychiatric interviewing: new directions for trainingS C Shea, J E MezzichPageof 266